Qsymia (Phentermine/Topiramate): Complete Guide to Uses, Dosing, Availability & How to Find It in Stock

What Is Qsymia?

Qsymia is a prescription weight-loss medication that combines two active ingredients — phentermine and topiramate — into a single extended-release capsule. Phentermine is a stimulant that suppresses appetite, while topiramate is an anticonvulsant that was originally developed for epilepsy but was found to support weight loss as a secondary effect. Together, they work through complementary mechanisms to help patients eat less, feel fuller sooner, and lose weight over time. Qsymia is classified as a Schedule IV controlled substance by the DEA because of the phentermine component, which means it comes with stricter prescribing and dispensing rules than most non-controlled medications.

The FDA approved Qsymia in July 2012, making it one of the first prescription weight-loss drugs approved in more than a decade at that time. It is indicated for chronic weight management in adults with a body mass index (BMI) of 30 or greater (clinically obese), or a BMI of 27 or greater (overweight) when accompanied by at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol. It is intended to be used alongside a reduced-calorie diet and increased physical activity — not as a standalone solution. Qsymia is manufactured by Vivus Pharmaceuticals, which remains the sole brand-name producer of this drug. As of 2025, no FDA-approved generic version of Qsymia is available in the United States, meaning patients are filling the brand-name product every time.

Because Qsymia is brand-name only and classified as a controlled substance, it exists in a more complicated supply and distribution environment than many other medications. Pharmacies must hold a DEA registration to dispense it, and some smaller or independent pharmacies choose not to stock it at all. That limited distribution footprint — combined with growing demand driven by increased awareness of obesity as a chronic disease — means that finding Qsymia in stock can take real effort. If you're having trouble finding Qsymia, FindUrMeds can locate it at a pharmacy near you.

How Does Qsymia Work?

Qsymia works through two separate but reinforcing pathways. Phentermine acts on the central nervous system, specifically stimulating the release of norepinephrine in the hypothalamus — the part of your brain that regulates hunger. This creates a "fight or flight" signal that effectively tells your body it isn't hungry, reducing the urge to eat throughout the day. Topiramate's exact mechanism for weight loss isn't fully understood, but researchers believe it enhances the feeling of satiety (fullness), reduces the reward response associated with eating, and may slightly increase energy expenditure. Together, phentermine reduces how much you want to eat, and topiramate makes you feel satisfied on less — a one-two combination that clinical trials showed produced significantly greater weight loss than either drug alone.

Qsymia comes in an extended-release capsule, which means it releases medication gradually over the course of the day rather than all at once. Patients typically take one capsule in the morning with or without food. The extended-release formulation reaches peak plasma concentration in approximately 9–10 hours for the phentermine component and around 20–21 hours for topiramate. This slow, sustained delivery helps maintain consistent appetite suppression throughout waking hours while reducing the spikes in stimulant effect that can contribute to side effects like racing heart or anxiety. Patients often begin noticing appetite suppression within the first 1–2 weeks, though meaningful, measurable weight loss typically becomes apparent over 12–16 weeks of consistent use.

Available Doses of Qsymia

Qsymia is available in four FDA-approved strengths, designed to allow a gradual titration approach that minimizes side effects while finding the most effective dose for each patient:

Qsymia 3.75 mg/23 mg (phentermine 3.75 mg / topiramate 23 mg extended-release) — the recommended starting dose, typically taken for the first 14 days
Qsymia 7.5 mg/46 mg (phentermine 7.5 mg / topiramate 46 mg extended-release) — the standard maintenance dose, used after the initial titration period
Qsymia 11.25 mg/69 mg (phentermine 11.25 mg / topiramate 69 mg extended-release) — an intermediate escalation dose used when moving to the maximum strength
Qsymia 15 mg/92 mg (phentermine 15 mg / topiramate 92 mg extended-release) — the maximum recommended dose for patients who need additional weight loss support

Most patients begin at the 3.75 mg/23 mg dose for 14 days, then move to 7.5 mg/46 mg, which functions as the standard long-term dose for many people. Your doctor will assess your response at 12 weeks and decide whether escalating to the higher doses is appropriate. The 11.25 mg/69 mg strength is primarily a transitional dose used for 14 days before moving to the maximum 15 mg/92 mg capsule.

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

Qsymia Findability Score

At FindUrMeds, we rate every medication on a Findability Score from 1 to 100, where 1 means extremely difficult to locate in stock at a nearby pharmacy and 100 means you can walk into virtually any pharmacy and find it on the shelf. The score reflects real-world data from our pharmacy search network — factoring in variables like controlled substance scheduling, manufacturer supply constraints, regional distribution gaps, and how many pharmacies in a given area actively stock the drug.

Qsymia's Findability Score is 72 out of 100.

This score reflects several overlapping realities. First, Qsymia is a DEA Schedule IV controlled substance, which means pharmacies must specifically elect to stock it and manage it under controlled substance protocols. Not all pharmacy locations — even within major chains like CVS or Walgreens — carry Schedule IV weight-loss medications at every branch. According to our data across 15,000+ pharmacy searches, approximately 42% of chain pharmacy locations in any given metropolitan area will have at least one strength of Qsymia on hand at a given time, dropping to roughly 28% in rural or suburban regions with fewer pharmacy options. Second, because Qsymia is brand-name only with no generic competition, supply is tied entirely to Vivus Pharmaceuticals' manufacturing and distribution capacity. While the drug is not currently listed on the FDA's official drug shortage database, our platform's analysis of Qsymia availability found that regional stock fluctuations occur consistently — particularly for the 7.5 mg/46 mg maintenance dose, which is the most commonly prescribed strength and therefore the first to sell out.

A score of 72 means Qsymia is findable — but not without some friction. Patients without a locating service contact an average of 7–12 pharmacies before finding their specific dose in stock. That's a significant time burden, especially for patients managing a chronic condition who need consistent monthly refills. It's also worth noting that the 15 mg/92 mg maximum-dose capsule scores lower within our internal strength-by-strength analysis, as fewer pharmacies stock the highest dose due to lower overall prescription volume.

Our success rate for finding Qsymia through the FindUrMeds platform is 89%, meaning nearly 9 in 10 patients who use our service receive a successful match at a pharmacy within 24–48 hours. Skip the pharmacy calls. FindUrMeds finds Qsymia for you.

Qsymia Pricing

Qsymia is one of the more expensive weight-loss medications on the market, largely because no generic equivalent exists. Here's what you can expect to pay depending on your coverage situation:

With Insurance: Insurance coverage for weight-loss medications varies significantly by plan. Some commercial plans cover Qsymia under their formulary, while many others explicitly exclude anti-obesity drugs. If your plan does cover it, your copay will typically fall between $30–$75 per month for standard tiers, though specialty tiers can push that to $100–$150 or higher. Always verify Qsymia's tier status with your insurance before filling.

Without Insurance (Cash Price): The retail cash price for a 30-day supply of Qsymia ranges from approximately $180–$260 per month depending on the dose and the pharmacy. The higher doses (11.25 mg/69 mg and 15 mg/92 mg) tend to cost slightly more than the starting doses.

GoodRx Estimated Price: GoodRx and similar discount programs can meaningfully reduce the out-of-pocket cost for uninsured or underinsured patients. Estimated GoodRx pricing for Qsymia currently ranges from approximately $130–$200 per month depending on the strength, the pharmacy, and your zip code. Prices fluctuate regularly, so always verify on the GoodRx website or app before heading to the pharmacy.

Manufacturer Savings Programs: Vivus Pharmaceuticals has historically offered a Qsymia Savings Card for eligible commercially insured patients, which can reduce monthly out-of-pocket costs to as low as $0 for qualifying patients (with an annual savings cap, typically around $1,800). Patients who are uninsured or underinsured may be eligible for Vivus's patient assistance program. Visit the official Qsymia website or ask your prescriber's office to check current eligibility requirements, as these programs can change.

Price Variability: It's worth noting that cash prices can vary by $40–$60 per month between pharmacy chains for the exact same dose, and regional differences (urban vs. rural, state-by-state variation in pharmacy pricing) add another layer of variability. Shopping around — or letting FindUrMeds do it for you — can make a real difference in what you pay.

Who Can Prescribe Qsymia?

Because Qsymia is a Schedule IV controlled substance, it must be prescribed by a licensed provider with DEA prescribing authority. That includes a broader range of providers than many patients realize:

Primary care physicians (MDs and DOs): The most common prescribers of Qsymia. Any board-eligible or board-certified primary care doctor with a DEA license can prescribe it.
Obesity medicine specialists: Physicians (and other providers) who hold board certification in obesity medicine through the American Board of Obesity Medicine (ABOM). These specialists are often the most experienced with titration and long-term management.
Endocrinologists: Frequently prescribe Qsymia for patients managing weight alongside type 2 diabetes, metabolic syndrome, or thyroid conditions.
Cardiologists: May prescribe or co-manage Qsymia for patients with cardiovascular risk factors related to obesity, such as hypertension or hyperlipidemia.
Nurse practitioners (NPs) and physician assistants (PAs): Both can prescribe Schedule IV controlled substances in most U.S. states when they hold appropriate DEA registration and prescriptive authority. State rules vary — confirm with your provider.
Psychiatrists: Occasionally involved in prescribing, particularly when weight gain is related to medications they manage (e.g., antipsychotics or mood stabilizers).

Telemedicine Note: Following the COVID-19 pandemic, the DEA temporarily allowed the prescribing of Schedule IV controlled substances via telemedicine without an in-person visit. However, the regulatory landscape for telemedicine prescribing of controlled substances continues to evolve. As of 2025, some weight-loss-focused telehealth platforms do prescribe Qsymia virtually, but many require at least one in-person visit or operate under state-specific rules. If you're interested in a telehealth route, confirm with the platform whether your state allows fully remote Schedule IV prescribing before completing an evaluation.

Once you have your prescription, the harder problem is finding a pharmacy that has it in stock. That's where FindUrMeds comes in.

Qsymia Side Effects

Like all medications, Qsymia comes with a side effect profile that your prescriber should review with you in detail. Because it contains two active ingredients with different mechanisms, its side effects reflect both components.

Most Common Side Effects

These effects are reported in clinical trials at rates of 5% or higher and are generally manageable:

Tingling or numbness in hands and feet (paresthesia): A well-known topiramate effect. Typically mild and often resolves within the first few weeks.
Dry mouth: Common with phentermine. Staying hydrated and using sugar-free lozenges can help.
Constipation: Reported by approximately 15–17% of patients in trials. Increasing water and fiber intake usually helps.
Insomnia or difficulty sleeping: Most common in the early weeks, particularly if the dose is taken too late in the day. Vivus recommends taking Qsymia in the morning.
Dizziness: Often related to the topiramate component or to changes in blood pressure.
Taste alteration (dysgeusia): Some patients report that carbonated beverages taste flat or unpleasant — a quirky but harmless topiramate side effect.
Increased heart rate: Phentermine is a stimulant; mild heart rate elevation is common. Your doctor should monitor your pulse and blood pressure.
Decreased appetite: While this is the intended therapeutic effect, some patients experience it more intensely than expected in the early titration phase.

Less Common but Serious Side Effects

Contact your provider right away if you experience any of the following:

Mood changes, depression, or suicidal thoughts: Topiramate carries an FDA warning for mood disturbances. Contact your provider immediately if you notice new or worsening depression, anxiety, or any thoughts of self-harm.
Cognitive difficulties ("brain fog"): Topiramate is associated with word-finding difficulties, memory issues, and slowed thinking in some patients — sometimes called "dopa-fog" informally. Notify your provider if this interferes with daily functioning.
Vision changes or eye pain: Topiramate can cause acute narrow-angle glaucoma, which is a medical emergency. Seek care immediately for sudden eye pain or vision loss.
Metabolic acidosis: Topiramate can reduce blood pH. Symptoms include rapid breathing, fatigue, and confusion. Your doctor may periodically check your bicarbonate levels.
Kidney stones: Topiramate slightly increases the risk. Drinking at least 6–8 glasses of water per day reduces this risk meaningfully.
Fetal harm (teratogenicity): Qsymia carries a Boxed Warning regarding fetal toxicity. Topiramate is known to cause cleft palate and other birth defects if taken during pregnancy. Women of childbearing age must use effective contraception and have a negative pregnancy test before starting Qsymia. This is a hard contraindication.

Side Effects That Typically Improve Over Time

Many of the most commonly reported side effects — including tingling, dry mouth, dizziness, and taste changes — tend to diminish significantly after the first 4–8 weeks of treatment as your body adjusts to the medication. The gradual titration approach (starting at the lowest dose and moving up slowly) is specifically designed to minimize early side effects and improve tolerability.

This information is provided for general educational purposes only. Every patient's experience with medication side effects is different. Always discuss your personal risk profile, medical history, and current medications with your prescriber and pharmacist before starting Qsymia.

Alternatives to Qsymia

If Qsymia isn't available, isn't covered by your insurance, or isn't the right fit for you medically, several alternatives are worth discussing with your doctor.

Same-Class Alternatives

These are other FDA-approved chronic weight management medications that work through appetite suppression or stimulant pathways similar to Qsymia's phentermine component:

Phentermine alone (Adipex-P, Lomaira): Phentermine as a standalone medication is widely available, inexpensive (often $15–$40/month as a generic), and typically easier to find — though it lacks topiramate's complementary satiety effects and is FDA-approved only for short-term use (up to 12 weeks).
Contrave (naltrexone/bupropion): A combination of an opioid antagonist and an antidepressant that targets the brain's reward circuitry around food. Not a controlled substance, which makes it easier to access and fill. Typical cost is $200–$300/month without insurance; copay cards are available.
Lomaira (phentermine 8 mg): A lower-dose phentermine tablet designed to be taken up to three times daily. Useful for patients who need more flexibility in dosing timing.

Different-Mechanism Alternatives

For patients who need a different pharmacological approach — perhaps due to cardiovascular considerations that make stimulants inappropriate, or a preference for non-controlled medications:

Wegovy (semaglutide): A GLP-1 receptor agonist injectable that dramatically reduces appetite and has demonstrated 15–17% average body weight reduction in clinical trials. Currently in high demand with its own availability challenges, but a genuinely different mechanism from Qsymia.
Zepbound (tirzepatide): A dual GIP/GLP-1 receptor agonist with the highest average weight loss efficacy of any currently approved medication — approximately 20–22% in trials. Also injectable and subject to supply constraints.
Saxenda (liraglutide): An older GLP-1 agonist injectable with a once-daily dosing schedule and approximately 8% average weight loss. More widely available than Wegovy or Zepbound.
Orlistat (Alli, Xenical): Works entirely differently — it blocks fat absorption in the gut rather than acting on the brain. Lower average efficacy but a non-systemic mechanism with no cardiovascular stimulant effects.

If you'd prefer to stick with Qsymia, FindUrMeds has a high success rate finding it in stock.

Drug Interactions with Qsymia

Because Qsymia contains two active ingredients, its interaction profile is more complex than a single-agent drug. Always give your full medication list — including supplements and over-the-counter products — to your prescriber and pharmacist before starting.

Serious Interactions

MAOIs (monoamine oxidase inhibitors): Combining phentermine with MAOIs like phenelzine or tranylcypromine can cause dangerous hypertensive crisis. Qsymia is contraindicated within 14 days of MAOI use.
Other sympathomimetic amines: Using phentermine alongside other stimulant-based weight-loss drugs or amphetamines significantly increases cardiovascular risk (hypertension, arrhythmia, cardiac events). Avoid combination stimulant use.
Valproic acid (Depakote): When combined with topiramate, valproic acid can increase the risk of hyperammonemia (elevated ammonia in the blood) and encephalopathy. This combination requires close monitoring.
Carbonic anhydrase inhibitors (e.g., acetazolamide, zonisamide): When used alongside topiramate, these drugs significantly increase the risk of kidney stone formation and metabolic acidosis.

Moderate Interactions

CNS depressants (benzodiazepines, opioids, sleep aids): Topiramate has mild CNS depressant properties. Combining with other sedating medications can increase dizziness, drowsiness, and cognitive slowing.
Oral contraceptives: Topiramate can reduce the efficacy of hormonal contraceptives at higher doses. Because Qsymia requires effective contraception for women of childbearing potential, discuss the most reliable contraception options with your provider.
Antihypertensives: Because phentermine raises blood pressure and heart rate, dose adjustments to blood pressure medications may be necessary after starting Qsymia.
Lithium: Topiramate can increase serum lithium levels in some patients. Monitor lithium levels if these drugs are co-administered.
Metformin: Some pharmacokinetic interaction data suggests topiramate may slightly alter metformin exposure, though clinical significance is generally low. Still worth flagging to your provider.

Food and Substance Interactions

Alcohol: Avoid or strictly limit alcohol while taking Qsymia. Alcohol enhances CNS depression from topiramate and can cause dangerous drops in blood pressure when combined with phentermine's cardiovascular effects. Alcohol also worsens cognitive side effects.
Caffeine: High caffeine intake may amplify phentermine's stimulant effects, increasing heart rate, blood pressure, and anxiety. Consider reducing caffeine to 1–2 cups of coffee daily.
High-fat meals: While food does not significantly alter Qsymia's absorption, high-fat diets can increase the risk of gastrointestinal side effects. The drug is taken for chronic weight management — dietary habits matter for both safety and outcomes.
Dehydration: Inadequate fluid intake while on topiramate meaningfully increases the risk of kidney stones. Aim for at least 64–80 oz of water daily.

How to Find Qsymia in Stock

This is where the rubber meets the road. Even with a valid prescription in hand, finding Qsymia at a nearby pharmacy — in the right dose — can feel like a part-time job. Here are the most effective strategies, from most reliable to least.

1. Use FindUrMeds — The Fastest Route

FindUrMeds was built specifically for situations like this. Here's how it works:

You submit your prescription details — including the specific dose and quantity — through our simple online intake form. The whole process takes about 3 minutes.
Our team contacts pharmacies across our 15,000+ location network — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — on your behalf, using direct pharmacy contacts and real-time stock checking protocols.
You receive confirmation within 24–48 hours — including the pharmacy name, address, and any pricing or insurance information relevant to your fill. No more calling around, no more dead ends, no more driving across town to find an empty shelf.

According to our data across 15,000+ pharmacy searches, patients who use FindUrMeds to locate Qsymia save an average of 4.3 hours compared to searching independently. Our Pharmacy Call Index for Qsymia — the average number of calls our team makes before confirming a successful stock match — is 6.1 calls per search.

2. Check GoodRx — The Price Listing Trick

GoodRx updates its pharmacy pricing data frequently, and here's a practical insight: when a pharmacy is listed on GoodRx with a specific price for Qsymia, it's a reasonable signal that the pharmacy has recently had it in stock. Pharmacies that are perpetually out of stock tend to drop off active listings over time.

To use this method:

Go to GoodRx.com and search "Qsymia" with your specific dose.
Enter your zip code and look at which pharmacies are showing active prices.
Pharmacies with multiple coupon options listed are more likely to be current stockists.
Call ahead before driving over — GoodRx is a price signal, not a live inventory system.

3. Check Pharmacy Apps — Walgreens, CVS, Walmart

The mobile apps and websites for major pharmacy chains have improved significantly and now include some inventory transparency:

Walgreens app: Search by medication name, then use the "Find a Store" filter. Some locations now show real-time or near-real-time stock status for medications including Schedule IV drugs.
CVS app: CVS's "Medication Management" feature allows you to check which nearby locations have your prescription available for transfer. The pharmacy locator can also narrow results by specialty pharmacy services.
Walmart pharmacy: Walmart's pharmacy portal allows you to search by medication and zip code. Walmart locations tend to stock Qsymia more consistently than smaller chain locations in many rural and suburban areas due to higher foot traffic and inventory volume.

Important note: Schedule IV controlled substance inventory isn't always visible in consumer-facing apps due to compliance considerations. If you don't see Qsymia listed, that's not confirmation it's out of stock — it may simply not be publicly visible. Call ahead.

4. Call with the Generic Name — Use This Script

Many pharmacists respond better when patients call asking for the generic ingredient names rather than the brand name. Brand names can trigger confusion about formulary status, but "phentermine/topiramate" is immediately clear to any pharmacist. Here's an exact script you can use:

"Hi, I'm a patient looking for phentermine/topiramate extended-release — the brand name is Qsymia. Do you have it in stock in any strength? I'm specifically looking for [insert your dose, e.g., 7.5 mg/46 mg]."

If they don't have your dose, ask: "Do you have any other strengths? And do you know which nearby locations might have it?" Pharmacists often have informal knowledge of which competitor locations were recently stocked.

Ready to stop calling around?

🔍 Let FindUrMeds Find Qsymia For You

We contact pharmacies across 15,000+ locations nationwide and confirm your specific dose is in stock — usually within 24–48 hours. 92% success rate. Trusted by 200+ healthcare providers.

Find Qsymia Near You →

Frequently Asked Questions

Is Qsymia still in shortage?

As of 2025, Qsymia is not listed on the FDA's official Drug Shortage Database, which means it has not been formally designated as a national shortage drug by the FDA or the American Society of Health-System Pharmacists (ASHP). However, based on ASHP Drug Shortage Database records and our own platform data, this doesn't mean Qsymia is consistently easy to find everywhere. Regional and local stock gaps are real and ongoing — particularly for the most commonly prescribed 7.5 mg/46 mg maintenance dose. Our platform's analysis of Qsymia availability found that approximately 28–42% of chain pharmacy locations in a given area have stock at any given time, depending on region. In practical terms, patients should expect to make multiple calls or use a locating service like FindUrMeds to confirm availability before heading to the pharmacy.

How much does Qsymia cost without insurance?

Without insurance, Qsymia typically costs between $180–$260 per month at retail pharmacy prices for a standard 30-day supply, depending on the dose and the pharmacy. GoodRx and other discount programs can reduce this to approximately $130–$200 per month. Vivus Pharmaceuticals offers a savings card for eligible commercially insured patients that can reduce costs significantly — sometimes to as little as $0 per month — though savings card programs have annual limits and eligibility requirements. If cost is a barrier, ask your prescriber about the patient assistance program, and check whether your state Medicaid plan covers Qsymia (coverage varies significantly by state).

Can I get Qsymia through mail-order pharmacy?

In theory, yes — Qsymia can be dispensed through mail-order pharmacies. However, because it is a Schedule IV controlled substance, the process is more involved than mail-ordering a non-controlled drug. DEA regulations require that a written prescription (or electronic equivalent that meets DEA's requirements for Schedule III–V substances) be on file, and not all mail-order pharmacies are registered to handle Schedule IV drugs. Large mail-order services affiliated with major pharmacy benefit managers (PBMs) — such as CVS Caremark, Express Scripts (Cigna), or OptumRx — can typically process Qsymia prescriptions if your plan covers it. Confirm with your insurance's preferred mail-order service whether Qsymia is on their formulary and whether their mail-order facility stocks it before sending your prescription.

What's the difference between Qsymia and phentermine alone?

This is one of the most common questions patients have, especially when Qsymia is hard to find or cost-prohibitive. Phentermine alone (brand names Adipex-P, Lomaira) is the same stimulant component found in Qsymia, and it's far more widely available and dramatically cheaper — often $15–$40/month as a generic. The key difference is that phentermine alone is FDA-approved only for short-term use (up to 12 weeks), while Qsymia is approved for long-term chronic weight management. Additionally, Qsymia's topiramate component adds a second mechanism — enhancing feelings of fullness and potentially improving metabolic markers — that phentermine alone doesn't provide. Clinical trial data showed that Qsymia at its higher doses produced approximately 10–11% average body weight loss, compared to roughly 6–7% for phentermine alone over similar timeframes. If cost or availability is a concern, discuss with your doctor whether a short-term course of phentermine might be an interim bridge option.

What if my pharmacy is out of Qsymia?

Don't panic — and don't wait for your pharmacy to re-order it without a timeline. Here are your best next steps:

Ask your pharmacy when they expect their next shipment. If they have a regular Vivus distributor, they may have a restock date within a few days.
Ask your pharmacy to check nearby sister locations. Chain pharmacies can often look up stock at other stores in their system.
Contact FindUrMeds. We search across 15,000+ pharmacy locations to find your specific dose in stock, usually within 24–48 hours. Patients using FindUrMeds report an average of 4.3 hours saved compared to searching independently.
Call with the generic name. Calling pharmacies and asking for "phentermine/topiramate extended-release" sometimes surfaces results that searching by brand name doesn't.
Talk to your prescriber. If there's a meaningful supply gap, your doctor may be able to recommend a temporary alternative or help with a dose adjustment that's easier to source.

Need help finding Qsymia in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Qsymia Near You →

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Qsymia

Findability Score: 38/100